These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12723391)

  • 21. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.
    Lin EC; Chan CH; Shao WC; Lin MF; Shiau S; Mueser KT; Huang SC; Wang HS
    Psychiatr Rehabil J; 2013 Dec; 36(4):243-9. PubMed ID: 24320832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.
    Färdig R; Lewander T; Melin L; Folke F; Fredriksson A
    Psychiatr Serv; 2011 Jun; 62(6):606-12. PubMed ID: 21632728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive individualized training versus social skills individualized training: a randomized trial in patients with schizophrenia.
    Bucci P; Piegari G; Mucci A; Merlotti E; Chieffi M; De Riso F; De Angelis M; Di Munzio W; Galderisi S
    Schizophr Res; 2013 Oct; 150(1):69-75. PubMed ID: 23962828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster randomised controlled trial.
    Asher L; De Silva M; Hanlon C; Weiss HA; Birhane R; Ejigu DA; Medhin G; Patel V; Fekadu A
    Trials; 2016 Jun; 17(1):299. PubMed ID: 27342215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Explanatory model of illness of the patients with schizophrenia and the role of educational intervention.
    Awan NR; Jehangir SF; Irfan M; Naeem F; Farooq S
    Schizophr Res; 2017 Dec; 190():68-73. PubMed ID: 28291691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a strength-oriented psychoeducation on caregiving competence, problem-solving abilities, psychosocial outcomes and physical health among family caregiver of stroke survivors: A randomised controlled trial.
    Cheng HY; Chair SY; Chau JPC
    Int J Nurs Stud; 2018 Nov; 87():84-93. PubMed ID: 30059815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of cognitive remediation on psychiatric symptoms of schizophrenia.
    Bark N; Revheim N; Huq F; Khalderov V; Ganz ZW; Medalia A
    Schizophr Res; 2003 Oct; 63(3):229-35. PubMed ID: 12957702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the Social Cognition Training Program in a Sample of Outpatients with Schizophrenia.
    Gil-Sanz D; Fernández-Modamio M; Bengochea-Seco R; Arrieta-Rodríguez M; Pérez-Fuentes G
    Clin Schizophr Relat Psychoses; 2016; 10(3):154-162. PubMed ID: 27732103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program.
    Prouteau A; Verdoux H; Briand C; Lesage A; Lalonde P; Nicole L; Reinharz D; Stip E
    Schizophr Res; 2005 Sep; 77(2-3):343-53. PubMed ID: 16085207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of dynamic cognitive intervention in rehabilitation of clients with schizophrenia.
    Hadas-Lidor N; Katz N; Tyano S; Weizman A
    Clin Rehabil; 2001 Aug; 15(4):349-59. PubMed ID: 11518436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
    J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
    Matsuda Y; Sato S; Iwata K; Furukawa S; Hatsuse N; Watanabe Y; Anzai N; Kishimoto T; Ikebuchi E
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):425-31. PubMed ID: 24506576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Description and impact of a structured psychoeducational and salutogenetic approach (InteGRO) to support the recovery of people with severe mental disorders].
    Veltro F; Nicchiniello I; Pica A; Pontarelli I; Iannone C; Pontarelli C; Zappone L; Vendittelli N
    Riv Psichiatr; 2018; 53(4):205-213. PubMed ID: 30087491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
    Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
    J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes.
    Chanpattana W; Kramer BA
    Schizophr Res; 2003 Sep; 63(1-2):189-93. PubMed ID: 12892873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I; Cechnicki A; Kalisz A
    Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.